Russell Investments »

Enliven Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $165 12 13.83

More positions owned by Russell Investments

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Nvidia Corp Common Stock (NVDA)
Alphabet Common Stock (GOOG)
Alphabet Common Stock (GOOGL)
Mastercard Incorporated Common Stock (MA)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Unitedhealth Group Common Stock (UNH)
Prologis Common Stock (PLD)
Equinix Common Stock (EQIX)
Welltower Common Stock (WELL)
Visa Common Stock (V)
Accenture Plc Ireland Shs Clas Common Stock (ACN)

View all positions for Russell Investments

Top funds holding Enliven Therapeutics

OrbiMed Advisors
5AM Venture Management
VR Adviser
Commodore Capital
Citadel Advisors
Fairmount Funds Management
RA Capital Management
Vanguard Group
Boxer Capital
Henderson Group
Logos Global Management
Charles Schwab Investment Management
Bank of New York Mellon
BML Capital Management
Barclays

View all funds holding Enliven Therapeutics